Intervention study of personalized low GI diet based on dynamic blood glucose monitoring in pre-diabetic population

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400085589

Enrollment

Unknown

Registered

2024-06-13

Start date

2024-06-30

Completion date

Unknown

Last updated

2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prediabetes

Interventions

experimental group:Personalized low GI diet based on CGM

control group:Refer to the dietary guidelines for diabetes

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ?The diagnostic criteria for impaired fasting blood glucose (IFG) were fasting plasma glucose (6.1mmol/L (110mg/dL) < FPG < 7.0mmol/L (100mg /dL), and plasma glucose (< 7.8mmol/L (140mg/dL) for 2 hours after glucose loading; ? The diagnostic criteria for impaired glucose tolerance (IGT) were fasting plasma glucose < 7.0mmol/L (100mg/dL) and 2h post-glucose loading plasma glucose 7.8mmol/L (140mg/dL) =2h PG < 11.1mmol/L (200mg/dL). ? Or both conditions ? and ? are satisfied 2, aged between 18 and 65 years old; 3, clear consciousness, can communicate normally, can use smart phones; 4. Agree to participate in the study and sign the informed consent;

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women; 2. Combined use of drugs that affect glucose metabolism, such as glucocorticoids, thyroxine, etc.; 3. Patients with abnormal liver and kidney function, or with serious diseases of other systems; 4. with mental diseases, malignant tumors, tuberculosis and other chronic wasting diseases; 5. Individuals diagnosed with diabetes or being treated for diabetes; 6. Repeated episodes of severe hypoglycemia or unconscious episodes of hypoglycemia judged by researchers; 7. Previous history of subtotal gastrectomy; 8. A history of alcohol/drug abuse; 9. One month before the trial, weight loss interventions were performed, including diet control or significant increase in exercise; 10. Have used a medication regimen or received diet therapy.

Design outcomes

Primary

Measure	Time frame
Fasting blood glucose;Blood sugar two hours after a meal;Glycosylated hemoglobin;	—

Secondary

Measure	Time frame
Fasting insulin;Insulin two hours after a meal;Blood routine examination;Blood lipid;urinalysis;urinalysis;Liver function;IVDR nuclear magnetic lipid detection;Intestinal flora;Body composition test;	—

Countries

China

Contacts

Public ContactChen Wei

Quzhou Hospital of Traditional Chinese Medicine

1307882466@qq.com+86 132 5108 0716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026